Diagnostic Medical · ISIN: FR0012202497

DMS GROUP: ANOTHER YEAR OF DYNAMIC GROWTH

Expansion of the product range and development of new solutions Strong growth expected in 2025 Focus on Imaging 2027! €46 M Revenue 9% Revenue growth vs 2023 January 16, 2025 – 5:45PM – Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 – ALDMS and FR001400IAQ8 – DMSBS), a specialist in hi...

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

This news feed is a compilation of company-relevant news from the most popular and widest-reaching newswire services. The feed is updated several times. For market-related publications, we recommend the X-Billboard, the Daily News Digest or our Premium Information Service.
Most recent update: 16.01.2025 | 17:45
16 January 2025 05:45PM
DMS GROUP: ANOTHER YEAR OF DYNAMIC GROWTH
Expansion of the product range and development of new solutions Strong growth expected in 2025 Focus on Imaging 2027! €46 M Revenue 9% Revenue growth vs 2023 January 16, 2025 – 5:45PM – Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 – ALDMS and FR001400IAQ8 – DMSBS), a specialist in hi...
20 December 2024 06:00PM
DMS GROUP : Verso Capital increases its Stake in DMS Group
December 20, 2024 – 6:00 PM – Diagnostic Medical Systems Group (Euronext Growth Paris: FR0012202497 – ALDMS et FR001400IAQ8 – DMSBS), a specialist in high-performance digital medical imaging systems for radiology and bone densitometry, announces an increase in Verso Capital's stake in DMS Group through the exercise...

The information service offers company-relevant news from leading newswire services in a compact form for a quick overview. When the detailed view is called up, further information can be accessed if required. The navigation elements in previewer mode allow you to quickly switch to the most frequently visited tool sections. From there, you can access further areas that can be used for your own research and analysis. Tip: The information platform now includes more than 50 mini-apps developed in-house.

AI First: Feel free to test the AI integration that will quickly put you on a par with financial journalists and research houses

Further information

The information presented in this section is secondary publications. The content corresponds to the source information. You can find information on the author of the news item in the detailed information of a publication. News relating to listed companies may have been created due to regulatory publication obligations, due to regular public relations work for PR or marketing reasons or by third parties against the background of investor information.

The combination of information and graphic elements contributes significantly to visual orientation and navigation through complex issues. This makes it easier to grasp, contextualize and process key content. Images, logos and other or comparable graphic and textual elements used on the information portal are used for visual navigation, are part of the original message or have illustrative purposes. All rights to these elements are held by the respective owners of the trademark or image rights. They are used without intent to infringe copyright or intellectual property rights. Image material provided via the distribution networks is treated as part of the original message and processed accordingly.

If you believe that copyright or intellectual property rights have been infringed by the presentation, please contact us immediately to clarify your concerns.